SCG
IPXL

Strategic Capital Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Strategic Capital Group’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$1.18M Buy
39,443
+1,058
+3% +$28.5K 0.37% 78
2014
Q1 		$1.01M Buy
38,385
+17,633
+85% +$441K 0.33% 87
2013
Q4 		$522K Sell
20,752
-16,667
-45% -$372K 0.41% 76
2013
Q3 		$766K Buy
37,419
+7,386
+25% +$153K 0.29% 107
2013
Q2 		$599K Buy
+30,033
New +$533K 0.3% 97

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Strategic Capital Group's IPXL Position: Q2 2014 in Review

Strategic Capital Group increased its Impax Laboratories, Inc. (IPXL) stake by 2.8% in Q2 2014, buying an estimated $28.5K and bringing the position to 39,443 shares worth $1.18M. The position accounts for 0.37% of the portfolio, ranked #78.

Strategic Capital Group first reported a position in IPXL in Q2 2013 and has held it in 5 quarters since. 185 funds tracked by Wall St. Rank hold IPXL as of Q2 2014.

  • Strategic Capital Group held 39,443 shares of Impax Laboratories, Inc. worth $1.18M as of Q2 2014.
  • Strategic Capital Group bought 1,058 Impax Laboratories, Inc. shares in Q2 2014, an estimated $28.5K.
  • Impax Laboratories, Inc. made up 0.37% of Strategic Capital Group's portfolio in Q2 2014, its #78 holding.
  • Strategic Capital Group first reported a position in Impax Laboratories, Inc. in Q2 2013 and has held it in 5 quarters since.
  • 185 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2014.

Based on Strategic Capital Group's 13F filing for Q2 2014, filed 14 Jul 2014.